Recordati Rare Diseases clinical trials
Acquired by RECORDATI GROUP, 2007 · source ↗
The registry lists 3 studies whose lead sponsor is Recordati Rare Diseases. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 15, 2025.
Before and after it joined RECORDATI GROUP
- First submitted before Recordati Rare Diseases became part of RECORDATI GROUP
- 0
- First submitted after Recordati Rare Diseases became part of RECORDATI GROUP
- 3
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Recordati Rare Diseases3 studies
Something wrong with this grouping? Tell us on the RECORDATI GROUP page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All RECORDATI GROUP studies →
- An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and PediatricsRecruitingNCT05040178
Sponsor listed in the registry: Recordati Rare Diseases · First submitted after Recordati Rare Diseases became part of RECORDATI GROUP
- Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods ApproachRecruitingNCT04176523
Sponsor listed in the registry: Recordati Rare Diseases · First submitted after Recordati Rare Diseases became part of RECORDATI GROUP
- Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)CompletedNCT04125927Phase 3
Sponsor listed in the registry: Recordati Rare Diseases · First submitted after Recordati Rare Diseases became part of RECORDATI GROUP